Young Research & Publishing Inc.

Investment Research Since 1978

Disclosure

  • About Us
    • Contributors
    • Archives
    • Dick Young’s Safe America
    • The Final Richard C. Young’s Intelligence Report
    • You’ve Read The Last Issue of Intelligence Report, Now What?
    • Dick Young’s Research Key: Anecdotal Evidence Gathering
    • Crisis at Vanguard
  • Investment Analysis
    • Bonds
    • Currencies and Gold
    • Dividend Investing
    • ETFs & Funds
    • Investment Strategy
    • Retirement Investing
    • Stocks
    • The Efficient Frontier
  • Investment Counsel
  • Dynamic Maximizers®
  • Retirement Compounders®
  • Free Email Signup

Can Hospitals Lower Drug Prices by Making Their Own?

January 23, 2018 By Young Research

By Image Point Fr @ Shutterstock.com

Four nonprofit hospital systems are applying to the FDA for approval to produce and market their own line of generic drugs. The hospitals are looking to produce generics for which there currently isn’t much competition. Melanie Evans writes in The Wall Street Journal:

The hospitals said they would prioritize production of generic drugs for which the market lacks competition, though they declined to specify which drugs they would produce first.

“We have no designs on being a major pharmaceutical power,” Intermountain President and Chief Executive Marc Harrison said. “This is a very specific problem we’re seeking to solve with a very specific solution,” he added.

The new company will “provide an alternative to sole-sourced, overpriced, in-short-supply medications,” Dr. Harrison said.

Prices for some generic drugs have soared where competition is scarce. A lack of manufacturing capacity has also caused shortages of some vital generic drugs in recent years, including painkillers, cancer drugs and saline.

The problem has complicated hospitals’ efforts to control rapidly rising drug spending.

The new nonprofit would set its own prices, a complicated and potentially fraught exercise in an environment where drug pricing is under intense scrutiny. The new nonprofit drug company will “understand our production costs really well” and won’t have to return equity to shareholders, as investor-owned companies do, said Dan Liljenquist, vice president of the enterprise initiative office at Intermountain.

Read more here.

KUTV 2 News: Leading U.S. health systems announce plans for not-for-profit generic drug company

Share this:

  • Email
  • Twitter
  • Facebook

You Might Also Like:

  • Hospitals Take a Step Back from Amazon’s Healthcare Push
  • House Prices are Also Prices
  • Tesla Slashes Prices after Missing on Deliveries
  • Author
  • Recent Posts
Young Research
Latest posts by Young Research (see all)
  • Happy Independence Day - July 4, 2022
  • Happy Memorial Day! - May 30, 2022
  • Happy Easter! - April 15, 2022

Search Young Research

Most Popular

  • Here’s Why You Need a 15-Year Retirement Investment Plan
  • Why Work When Taxes Take It All?
  • Vanguard Wellesley (VWINX) vs. Wellington (VWELX): Which Fund is Best?
  • Are Google, Amazon, and Microsoft About to Crash This Specialized Real Estate Market?
  • The Power of a Compound Interest Table
  • What Happens to Your Passwords When You Die?
  • Regulators' Bungled Attempts to Cut Emissions Drove Oil Prices Higher
  • RURAL RENAISSANCE: America Finds the Country Again
  • Is the Great Job Boom Over?
  • Corporate Bond Yields: What You Can Earn Today

Don’t Miss

Default Risk Among the Many Concerns with Annuities

Risk and Reward: An Efficient Frontier

How to be a Billionaire: Proven Strategies from the Titans of Wealth

Could this Be the Vanguard GNMA Winning Edge?

Cryptocosm and Life After Google

Warning: Avoid Mutual Fund Year End Distributions

Is Gold a Good Long-term Investment?

How to Invest in Gold

Vanguard Wellington (VWELX): The Original Balanced Fund

What is the Best Gold ETF for Investing and Trading?

Procter & Gamble (PG) Stock: The Only True Dividend King

The Dividend King of the North

You’ll Love This if You’re Dreaming of an Active Retirement Life

RSS The Latest at Richardcyoung.com

  • BIDEN OUT OF TOUCH: Will America See Recession, or Worse?
  • Your Average Joe – a Man Out of Touch
  • “Talk to Me, Goose!” Time Flies in Top Gun: Maverick
  • The Dangers of Politicizing the Federal Reserve
  • FOOD SHORTAGE: Four Reasons Farms Are Suffering
  • Rich Grandchild, Poor Grandchild
  • Facebook Braces for “Worst Downturn in Recent History”
  • Happy Independence Day
  • For Investors Who Want to Stop Worrying About a Market Crash
  • Breaking News: House Election Update

About Us

  • About Young Research
  • Archives
  • Contributors

Our Partners

  • Richard C. Young & Co.
  • Richardcyoung.com

Copyright © 2022 | Terms & Conditions

 

Loading Comments...
 

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.